You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OKUR Award Disclosure
Saccomano Nicholas A · SEC Form 4 · Filed Aug 11, 2026
Award
Reported value range
Not reported
Saccomano Nicholas A President And CEO
OKUR
Transaction date
Aug 7, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 4 days later
OKUR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Class A Common Stock
- Quantity / price
- 542,232 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001609284-26-000004
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | $0 |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR Current | Award | Aug 7, 2026 | Not reported |